453
Participants
Start Date
September 11, 2017
Primary Completion Date
April 30, 2022
Study Completion Date
October 25, 2023
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
Atezolizumab will be administered via IV infusion once every three weeks (QW3).
Vinorelbine
Vinorelbine will be administered per relevant local guidelines and Summary of Product Characteristics (SmPC) management.
Gemcitabine
Gemcitabine will be administered per relevant local guidelines and SmPC management.
Mater Misericordiae University Hospital - Institute for Cancer Research, Dublin
UZ Brussel, Brussels
Centre Hospitalier de Luxembourg, Luxembourg
UZ Leuven Gasthuisberg, Leuven
Spital STS AG - Spital Thun Medizin Onkologie; MEDIZINISCHE KLINIK, Thun
Complex Oncology Center (COC)-Plovidiv, Plovdiv
Odense Universitetshospital, Onkologisk Afdeling R, Odense C
Umhat Dr Georgi Stranski; Clinic of Chemotherapy, Pleven
Grand Hôpital de Charleroi Notre Dame, Charleroi
Ospedale Regionale di Bellinzona Medizin Onkologie, Bellinzona
Kantonsspital Winterthur; Medizinische Onkologie, Winterthur
Evang. Lungenklinik Berlin Klinik für Pneumologie, Berlin
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia, Santiago de Compostela
Azienda Ospedaliera San Gerardo di Monza, Monza MI
LungenClinic Großhansdorf GmbH; Klinische Forschung, Großhansdorf
Hospital Universitario de la Princesa; Servicio de Oncologia, Madrid
Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid
Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Málaga
Hospital General Universitario J.M Morales Meseguer; Servicio de Oncologia, Murcia
Centro Estatal de Cancerologia de Chihuahua; ONCOLOGY, Chihuahua City
Fachklinik für Lungenerkrankungen, Immenhausen
Klinikum der Philipps-Universität Marburg, Marburg
Hospital Universitario Virgen Macarena; Servicio de Oncologia, Seville
Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia
Ospedale Provinciale Santa Maria Delle Croci; Oncologia Medica, Ravenna
Hospital de Cruces; Servicio de Oncologia, Bilbao
Universitätsklinikum Tübingen; Innere Medizin VIII, Medizinische Onkologie und Pneumologie, Tübingen
Oncologico Potosino, San Luis Potosí City
Asklepios Klinik Gauting; Onkologisches Studienzentrum, Gauting
Universitätsklinikum Regensburg; Klinik und Poliklinik für Innere Medizin II, Pneumologie, Regensburg
Bach Mai Hospital, Hanoi
Beijing Cancer Hospital, Beijing
Max Super Speciality Hospital, New Delhi
Indraprastha Apollo Hospitals, New Delhi
Rajiv Gandhi Cancer Inst.&Research Center; Medical Oncology, New Delhi
Shanghai Chest Hospital, Shanghai
Anhui Provincial Hospital, Hefei
Oncomedica S.A., Montería
Tianjin Cancer Hospital, Tianjin
Oncocenter Timisoara, Timi?oara
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
HealthCare Global Cancer Centre; Medical Oncology, Ahmedabad
Kailash Cancer Hospital and Research Center, Vadodara
Tata Memorial Hospital; Dept of Medical Oncology, Mumbai
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca; Oncologie Medicala, Cluj-Napoca
P.D. Hinduja Nat. Hospital & Med. Research Centre, Mahim(West)
Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute; Department of Rheumatologz, Mumbai
Centrul de Radioterapie AMETHYST, Floreşti
Hu Nan Provincial Cancer Hospital, Changsha
Grant Medical Foundation, Ruby Hall Clinic, Pune
Deenanath Mangeshkar Hospital & Research Centre, Pune
HCG Manavata Cancer Centre, Nashik
Union Hospital of Tongji Medical College, Dept. of Cancer Center; Cancer Center, Wuhan
Indo-American Cancer Hospital & Research Center, Hyderabad
Oncólogos de Occidente, Pereira
Cho Ray Hospital, Hochiminh City
Tata Medical Center; Department of Medical Oncology, Kolkata
Fundación CENIT para la Investigación en Neurociencias, Buenos Aires
Hospital Privado de Comunidad, Mar del Plata
Clinica Viedma S.A., Viedma
Hospital Nossa Senhora da Conceicao, Porto Alegre
Hospital Sao Lucas - PUCRS, Porto Alegre
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo
BCCA-Vancouver Cancer Centre, Vancouver
Regional health authority A vitalite health network, Moncton
Ottawa Hospital Research Institute, Ottawa
Princess Margaret Cancer Center, Toronto
Jewish General Hospital, Montreal
Fundacion Cardioinfantil, Bogotá
University Hospital Limerick - Clinical Trials Department, Limerick
Fundación Centro de Investigación Clínica CIC, Medellín
Kazakh Scientific Research Institution Of Oncology and Radiology, Almaty
Fakultni nemocnice Olomouc; Pneumologicka klinika, Olomouc
Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin II, Halle
Azienda Ospedaliera San Camillo Forlanini; U.O.C. Pneumologia Ad Indirizzo Oncologico 1, Rome
Almaty Oncology Center, Almaty
Health Pharma Professional Research, Mexico City
Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy; Oddzial Iii, Otwock
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad; Klinika Nowot.Pluca i Klatki Piers, Warsaw
CHUC - Unidade de Pneumologia Oncológica; Hospital de Dia de Oncologia Edificio Sao Jeronimo, Coimbra
IPO do Porto; Servico de Oncologia Medica, Porto
Specializovana nemocnica sv. Svorada Zobor, n.o.; Oddelenie klinickej onkologie, Nitra
Fakultna nemocnica Trnava, Trnava
Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona
Clatterbridge Cancer Centre, Bebington
Birmingham Heartlands Hospital, Birmingham
Royal Cornwall Hospital; Dept of Clinical Oncology, Cornwall
New Victoria Hospital, Glasgow
University College London Hospitals NHS Foundation Trust - University College Hospital, London
Christie Hospital Nhs Trust; Medical Oncology, Manchester
YORK DISTRICT HOSPITAL; Haematology/Oncology Department, York
Hoffmann-La Roche
INDUSTRY